Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangmen New Era External Use Drug is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of topical and external-use medications. Based in Jiangmen, Guangdong Province, the company operates GMP-certified production lines for various dosage forms, including ointments, creams, liniments, and solutions. Its product portfolio primarily focuses on dermatological treatments, analgesics, and antiseptic agents, serving both domestic and international markets. The company is recognized for its established brands in the field of external medicine, providing solutions for skin conditions and musculoskeletal pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangmen New Era External Use Drug.